JAK2V617F allele burdenBiomarker1 paperLatestNov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01Frontiers in OncologyReview·26 AugNeutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasmsNeutrophil-to-lymphocyte ratio
Frontiers in OncologyReview·26 AugNeutrophil-to-lymphocyte ratio as a gene-specific biomarker of JAK2-driven inflammation across CHIP and myeloproliferative neoplasmsNeutrophil-to-lymphocyte ratio